BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33680908)

  • 1. Down-Regulation of
    Li X; Wu P; Tang Y; Fan Y; Liu Y; Fang X; Wang W; Zhao S
    Front Oncol; 2020; 10():544476. PubMed ID: 33680908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition.
    Wu Y; Dai F; Zhang Y; Zheng X; Li L; Zhang Y; Cao J; Gao W
    Mol Ther Oncolytics; 2021 Sep; 22():152-165. PubMed ID: 34514096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1.
    Gao W; Wu Y; He X; Zhang C; Zhu M; Chen B; Liu Q; Qu X; Li W; Wen S; Wang B
    J Cancer; 2017; 8(12):2356-2368. PubMed ID: 28819440
    [No Abstract]   [Full Text] [Related]  

  • 4. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
    Wang Z; Huang C; Zhang A; Lu C; Liu L
    Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA ciRS-7 promotes laryngeal squamous cell carcinoma development by inducing TGM3 hypermethylation via miR-432-5p/DNMT3B axis.
    Zhao K; Ye F; Gao P; Zhu X; Hao S; Lou W
    Pathol Res Pract; 2022 Dec; 240():154193. PubMed ID: 36356335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis.
    Cui W; Meng W; Zhao L; Cao H; Chi W; Wang B
    Int J Oncol; 2019 Jun; 54(6):2005-2018. PubMed ID: 31081043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
    Zhu M; Zhang C; Chen D; Chen S; Zheng H
    Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma.
    Li Y; Liu J; Hu W; Zhang Y; Sang J; Li H; Ma T; Bo Y; Bai T; Guo H; Lu Y; Xue X; Niu M; Ge S; Wen S; Wang B; Gao W; Wu Y
    Onco Targets Ther; 2019; 12():10441-10453. PubMed ID: 31819525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).
    Li N; Cheng C; Wang T
    Onco Targets Ther; 2020; 13():4495-4505. PubMed ID: 32547080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Hui L; Zhang J; Guo X
    Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-140-5p targeted FGF9 and inhibited the cell growth of laryngeal squamous cell carcinoma.
    Wang Y; Huang Q; Li F
    Biochem Cell Biol; 2020 Apr; 98(2):83-89. PubMed ID: 31867983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells.
    Yang B; Zang J; Yuan W; Jiang X; Zhang F
    Exp Ther Med; 2021 Apr; 21(4):317. PubMed ID: 33717260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Nucleolar RNA Host Gene 12 (SNHG12) Promotes Proliferation and Invasion of Laryngeal Cancer Cells via Sponging miR-129-5p and Potentiating WW Domain-Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Expression.
    Li J; Sun S; Chen W; Yuan K
    Med Sci Monit; 2019 Jul; 25():5552-5560. PubMed ID: 31348766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
    Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
    Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of miR-17-5p suppresses cell proliferation and promotes cell apoptosis by directly targeting PIK3R1 in laryngeal squamous cell carcinoma.
    Wang JX; Jia XJ; Liu Y; Dong JH; Ren XM; Xu O; Liu SH; Shan CG
    Cancer Cell Int; 2020; 20():14. PubMed ID: 31938022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145.
    Liu S; Duan W
    J Cell Biochem; 2019 May; 120(5):8272-8279. PubMed ID: 30485513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MIR100HG promotes cancer cell proliferation, migration and invasion in laryngeal squamous cell carcinoma through the downregulation of miR-204-5p.
    Huang Y; Zhang C; Zhou Y
    Onco Targets Ther; 2019; 12():2967-2973. PubMed ID: 31114240
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
    Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
    Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.